primary antibodies specific for phosphorylated (p)-marcks (ser167/170; d13e4 xp) (Cell Signaling Technology Inc)
Structured Review

Primary Antibodies Specific For Phosphorylated (P) Marcks (Ser167/170; D13e4 Xp), supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies specific for phosphorylated (p)-marcks (ser167/170; d13e4 xp)/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type"
Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type
Journal: Antioxidants
doi: 10.3390/antiox11081600
Figure Legend Snippet: ROS production is suppressed by PKCβ KO and PKC inhibitor Staurosporine, and MARCKS level and Ser167/170 phosphorylation are not affected in PKCβ KO cells. THP-1-derived PKCβ KO cells (generated using the CRISPR/Cas9 technique) and THP-1 WT cells were differentiated with 100 nM calcitriol for 5 d. Subsequently, ROS production was induced by PMA (100 nM) and determined (in RLU/s) via luminol-amplified chemiluminescence. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 60 min following stimulation ( B ) of total ROS generated by differentiated THP-1 WT and PKCβ KO cells (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 60 min following stimulation ( D ) of intracellular ROS generated by differentiated THP-1 and PKCβ KO cells (representative experiment, n = 3). ( E ) Primary human monocytes were incubated in medium with Staurosprine (Stauro; 80 nM) for 2.5 h. Subsequently, PMA-induced total ROS production was assessed and depicted as cumulated ROS production within 30 min following stimulation (mean ± SD; n = 2). ( F ) THP-1 WT and PKCβ KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested. Total cell extracts were prepared, and MARCKS ED phosphorylation (Ser167/170) and protein levels were determined (Western Blot; loading control: GAPDH; representative experiment, n = 3).
Techniques Used: Phospho-proteomics, Derivative Assay, Generated, CRISPR, Amplification, Incubation, Western Blot, Control
Figure Legend Snippet: Increased monocytic ROS production following TNF long-term preincubation is dependent on MARCKS and PKCβ. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 180 min ( B ) of opsonized bacteria-induced (≥5 bacteria/cell) total ROS generated by 5 d calcitriol-differentiated THP-1 cells following preincubation with 80 ng/mL TNF for 48 h (i.e., added at day 3). Total ROS production was assessed via luminol-amplified chemiluminescence (in RLU/s) (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 180 min ( D ) of opsonized bacteria-induced intracellular ROS generated by differentiated THP-1 cells following TNF preincubation as described in ( A ) (representative experiment, n = 3). ( E , F ) Kinetics ( E ) and the respective cumulated production within 30 min ( F ) of PMA-induced (100 nM) total ROS generated by primary human monocytes following TNF preincubation (80 ng/mL TNF for 48 h; representative experiment, n = 4). ( G ) Cumulated intracellular ROS production in MARCKS WT and KO clones (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3). ( H ) Cumulated intracellular ROS production in THP-1 and PKCβ KO cells (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3).
Techniques Used: Bacteria, Generated, Amplification, Clone Assay, Incubation
